CRISPR Journal

Papers
(The median citation count of CRISPR Journal is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
CRISPR-Cas Gene Perturbation and Editing in Human Induced Pluripotent Stem Cells481
Exploring the Cytoplasmic Retention of CRISPR-Cas9 in Eukaryotic Cells: The Role of Nuclear Localization Signals and Ribosomal Interactions50
Hairpin Internal Nuclear Localization Signals in CRISPR-Cas9 Enhance Editing in Primary Human Lymphocytes48
Adaptation by Type V-A and V-B CRISPR-Cas Systems Demonstrates Conserved Protospacer Selection Mechanisms Between Diverse CRISPR-Cas Types44
Gene Editing Corrects In Vitro a G > A GLB1 Transition from a GM1 Gangliosidosis Patient40
Increasing Genome Editing Efficiency of Cas9 Nucleases by the Simultaneous Use of Transcriptional Activators and Histone Acetyltransferase Activator40
CRISPR Comparison Toolkit: Rapid Identification, Visualization, and Analysis of CRISPR Array Diversity37
Will Advances in Genetic Medicine Lessen the Need for Germline Modifications?36
Inference of CRISPR Edits from Sanger Trace Data33
Editing Properties of Base Editors with SpCas9-NG in Discarded Human Tripronuclear Zygotes31
A Taxonomic and Phylogenetic Classification of Diverse Base Editors30
Acknowledgment of Reviewers 202230
Curing “GFP-itis” in Bacteria with Base Editors: Development of a Genome Editing Science Program Implemented with High School Biology Students28
Novel CRISPR-Associated Gene-Editing Systems Discovered in Metagenomic Samples Enable Efficient and Specific Genome Engineering27
Advances in Cas12a-Based Amplification-Free Nucleic Acid Detection27
Opposing Human Genetic Engineering26
Gene Editing and Rett Syndrome: Does It Make the Cut?24
Generation of a Commercial-Scale Founder Population of Porcine Reproductive and Respiratory Syndrome Virus Resistant Pigs Using CRISPR-Cas22
Early Detection of Wildlife Disease Pathogens Using CRISPR-Cas System Methods21
Generation of Human Isogenic Induced Pluripotent Stem Cell Lines with CRISPR Prime Editing20
Implementing CRISPR-Cas9 Yeast Practicals into Biology Curricula20
Increasing the Targeting Scope of CRISPR Base Editing System Beyond NGG20
Efficient Homology-Directed Repair with Circular Single-Stranded DNA Donors17
CRISPR Crops and Sustainable Agriculture17
Comprehensive Analysis of CRISPR-Cas9 Editing Outcomes in Yeast Xanthophyllomyces dendrorhous17
The Roles and Responsibilities of Scientific Journals in Research Governance: Editorial Policymaking at Nature and Springer Nature (1995–2023)16
CRISPR Rewrites the Future of Medicine15
CRISPR à la carte15
A Story of Perseverance: An Interview with Matthew Porteus15
Evolutionary Biology and Gene Editing of Cat Allergen, Fel d 114
Widespread Impact of Natural Genetic Variations in CRISPR-Cas9 Outcomes14
Gene Editing in the Chagas Disease Vector Rhodnius prolixus by Cas9-Mediated ReMOT Control13
Engineered Antiviral Sensor Targets Infected Mosquitoes13
Evolution of Type IV CRISPR-Cas Systems: Insights from CRISPR Loci in Integrative Conjugative Elements of Acidithiobacillia12
Combined Theoretical, Bioinformatic, and Biochemical Analyses of RNA Editing by Adenine Base Editors12
dCas9 Tells Tales: Probing Gene Function and Transcription Regulation in Cancer12
Institutional Bioethics: From Critical Interdisciplinarity to Cosmopolitanism12
Automated Good Manufacturing Practice-Compatible CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells for Clinical Treatment of β-Hemoglobinopathies12
Engineering CjCas9 for Efficient Base Editing and Prime Editing11
CRISPR Momentum in the Clinic and the Field11
Specific High-Sensitivity Enzymatic Reporter UnLOCKing-Mediated Detection of Oncogenic BCR::ABL1 and EGFR Rearrangements11
Fanzors: Mysterious TnpB-Like Bacterial Transposon-Related RNA-Guided DNA Nucleases of Eukaryotes11
Rational Engineering of CRISPR-Cas9 Nuclease to Attenuate Position-Dependent Off-Target Effects11
A PCR-Induced Mutagenesis-Restriction Fragment Length Polymorphism Method for the Detection of CRISPR-Induced Indels10
A Fluorescent Reporter Mouse for In Vivo Assessment of Genome Editing with Diverse Cas Nucleases and Prime Editors10
Enhancements of the CRISPR-Cas System in the Silkworm Bombyx mori10
Affordable Pricing of CRISPR Treatments is a Pressing Ethical Imperative10
A Protein-Cutting CRISPR Complex Caught in Action9
A Multiplexed Cas13-Based Assay with Point-of-Care Attributes for Simultaneous COVID-19 Diagnosis and Variant Surveillance9
The CRISPR Revolution in the Drug Discovery Workflow: An Industry Perspective9
Bacterial Retrons Enable Precise Gene Editing in Human Cells9
Rapid and Technically Simple Detection of SARS-CoV-2 Variants Using CRISPR Cas12 and Cas139
It's a Knockout for Cat Allergies?9
Warrior Spirit: An Interview with Victoria Gray, Sickle Cell Pioneer9
Introducing Faith-Based Claims to Ethical Discourse on Scientific Matters8
Acknowledgment of Reviewers 20238
Cas12a-Capture: A Novel, Low-Cost, and Scalable Method for Targeted Sequencing8
Spotlight on Genetic Design in a Spotted Wing Crop Killer8
CRISPR-Cas9-Mediated Correction of TSC2 Pathogenic Variants in iPSCs from Patients with Tuberous Sclerosis Complex Type 28
Navigating Viral Space with CRISPR Technologies7
Five Years of Progress in CRISPR Clinical Trials (2019–2024)7
Reduction of Pre-Existing Adaptive Immune Responses Against SaCas9 in Humans Using Epitope Mapping and Identification7
Base Editing of Somatic Cells Using CRISPR–Cas9 in Drosophila7
Rapid Variant Pathogenicity Analysis by CRISPR Activation of CRB1 Gene Expression in Patient-Derived Fibroblasts7
Genome Editing Headwinds: Can CRISPR Stay on Target?7
The New Old Colonialism7
CRISPR-Cas9 Gene Editing Protects from the A53T-SNCA Overexpression-Induced Pathology of Parkinson's Disease In Vivo7
Genome Editing Therapy for the Blood: Ex Vivo Success and In Vivo Prospects7
Trichostatin A for Efficient CRISPR-Cas9 Gene Editing of Human Pluripotent Stem Cells7
Moving Therapeutic Genome Editing into Global Clinical Trials and Medicine7
Correction to: Give Cas a Chance: An Actionable Path to a Platform for CRISPR Cures, by Fyodor D. Urnov [DOI: 10.1089/crispr.2024.0082]6
Clonally Selected Lines After CRISPR-Cas Editing Are Not Isogenic6
Characterization of Research Support of Genome Editing Technologies and Transition to Clinical Trials6
Extreme Genome Editing6
CRISPR-Cas9 Long-Read Sequencing for Mapping Transgenes in the Mouse Genome6
Special Issue: CRISPR Trials6
Special Issue: Manipulating the Microbiome with CRISPR6
Bio-Orthogonal Chemistry Conjugation Strategy Facilitates Investigation of N-methyladenosine and Thiouridine Guide RNA Modifications on CRISPR Activity6
Novel off-Targeting Events Identified after Genome Wide Analysis of CRISPR-Cas Edited Pigs6
PASTE: The Way Forward for Large DNA Insertions6
Correction to: APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels by Rieffer et al. The CRISPR Journal, 2023;6(5):430–446; DOI: 10.1089/crispr.2023.00276
Diverse Class 2 CRISPR Effectors as Active Nucleases with Expanded Targeting Capabilities6
An Efficient and Cost-Effective Novel Strategy for Identifying CRISPR-Cas-Mediated Mutants in Plant Offspring5
CRISPR-Cas12a Genome Editing at the Whole-Plant Level Using Two Compatible RNA Virus Vectors5
A Reset for Bioethics: A Statement from the Global Observatory for Genome Editing5
CRISPR-Cas9-Mediated Targeting of Multidrug Resistance Genes in Methicillin-Resistant Staphylococcus aureus5
Recalibrating Health Governance, Equity, and Reproductive Rights in India: A Case Study from the Global South5
Celebrating a Decade of CRISPR-Fueled Genome Editing5
Electroporation-Mediated Delivery of Cas9 Ribonucleoproteins Results in High Levels of Gene Editing in Primary Hepatocytes5
Viral Delivery of Compact CRISPR-Cas12f for Gene Editing Applications4
Efficient and Economical Targeted Insertion in Plant Genomes via Protoplast Regeneration4
Science with Society at Science Gallery Bengaluru4
APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels4
High-Throughput Imaging of CRISPR- and Recombinant Adeno-Associated Virus–Induced DNA Damage Response in Human Hematopoietic Stem and Progenitor Cells4
Green Fluorescent Protein Tagged Polycistronic Reporter System Reveals Functional Editing Characteristics of CRISPR-Cas4
Correction to: Genotyping MUltiplexed-Sequencing of CRISPR-Localized Editing (GMUSCLE): An Experimental and Computational Approach for Analyzing CRISPR-Edited Cells by Zhang et al. The CRISP4
Discovery and Characterization of Novel Type V Cas12f Nucleases with Diverse Protospacer Adjacent Motif Preferences4
Reprogramming of Human B Cells from Secreting IgG to IgM by Genome Editing4
Optimization of Genomewide CRISPR Screens Using AsCas12a and Multi-Guide Arrays4
Introducing Perspectives from the Global Observatory for Genome Editing4
Genetic Manipulation of a CAST of Characters in a Microbial Community4
Novel and Engineered Type II CRISPR Systems from Uncultivated Microbes with Broad Genome Editing Capability4
Modified Cas9-Guided Oxford Nanopore Technology Sequencing Uncovers Single and Multiple Transgene Insertion Sites in a Zebrafish Melanoma Model4
Facing Systemic Uncertainty, Can the CRISPR Community Stay the Course?4
Genome Editing in Apicomplexan Parasites: Current Status, Challenges, and Future Possibilities3
CRISPRi-Mediated Treatment of Dominant Rhodopsin-Associated Retinitis Pigmentosa3
Genomic and Transcriptomic Analyses of Prime Editing Guide RNA–Independent Off-Target Effects by Prime Editors3
CRISPR-Cas9 Genome Editing Uncovers the Mode of Action of Methoprene in the Yellow Fever Mosquito, Aedes aegypti3
Enhanced Myogenesis by Silencing Myostatin with Nonviral Delivery of a dCas9 Ribonucleoprotein Complex3
Response to Cook et al. re: Novel Off-Targeting Events Identified After Genome Wide Analysis of CRISPR-Cas Edited Pig3
Toward a Global Deliberative System for Genome Editing3
Modulating CRISPR-Cas Genome Editing Using Guide-Complementary DNA Oligonucleotides3
Developing Bottom-Up Induced Pluripotent Stem Cell Derived Solid Tumor Models Using Precision Genome Editing Technologies3
Predicting Mutations Generated by Cas9, Base Editing, and Prime Editing in Mammalian Cells3
As CRISPR Technologies Ripen, What Should We Prioritize?3
AI and SynBio Meet CRISPR Heralding a New Genome Editing Era3
Acknowledgment of Reviewers 20213
CRISPR's Path to the Clinic2
Model System to Analyze RNA-Mediated DNA Repair in Mammalian Cells2
CRISPR and the Plant Pathologists' Holy Grail2
Establishment of a CRISPR-Cas9-Mediated Genome Editing System in Flax2
Biotechnologies in the World: On Global Asymmetries and the Need for Cosmopolitanism2
Advances in Gene Therapy for Sickle Cell Disease: From Preclinical Innovations to Clinical Implementation and Access Challenges2
JACKIE: Fast Enumeration of Genome-Wide Single- and Multicopy CRISPR Target Sites and Their Off-Target Numbers2
Highly Efficient One-Step Tagging of Endogenous Genes in Primary Cells Using CRISPR-Cas Ribonucleoproteins2
Functional Characterization of Type III-A CRISPR-Cas in a Clinical Human Methicillin-R Staphylococcus aureus Strain2
Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for The CRISPR Journal2
A Mutation-Agnostic Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy2
Optimizing Genome Editing in Mollusks (Crassostrea gigas) in Vitro Validation of sgRNA and Identifying Key Factors Influencing Efficiency2
Periodontal Disease Pathogens, Pathogenesis, and Therapeutics: The CRISPR-Cas Effect2
The Promises and Pitfalls of CRISPR-Mediated Base Editing in Stem Cells2
Special Issue on CRISPR Diagnostics2
Monitoring the Land and Sea: Enhancing Efficiency Through CRISPR-Cas Driven Depletion and Enrichment of Environmental DNA2
Search for Origins of Anti-CRISPR Proteins by Structure Comparison2
Efficient Generation of SOCS2 Knock-Out Sheep by Electroporation of CRISPR-Cas9 Ribonucleoprotein Complex with Dual-sgRNAs2
Enrichment of Allelic Editing Outcomes by Prime Editing in Induced Pluripotent Stem Cells2
Compact Cje3Cas9 for Efficient In Vivo Genome Editing and Adenine Base Editing2
CRISPR Empowers Tree Bioengineering for a Sustainable Future2
Identification of a Guide RNA Targeting an Ultraconserved Element for Evaluation of Cas9 Genome Editors Across Mammalian Species2
Correction to: Generation of a Commercial-Scale Founder Population of Porcine Reproductive and Respiratory Syndrome Virus Resistant Pigs Using CRISPR-Cas by Burger et al. The CRISPR Journal,2
Special Issue: Manipulating the Microbiome with CRISPR2
0.37909007072449